Live
The US health regulator has given its final approval to Ajanta Pharma for the generic version of its acute migraine pain relief drug Zolmitriptan tablets.
Ajanta Pharma has said in a regulatory filing that “The company received the final approval for Zolmitriptan tablets (2.5 mg, 5 mg) from the US Food and Drug Administration (USFDA). Zolmitriptan is used in the acute treatment of migraine and is a bio-equivalent generic version of Zomig.”
It further added that Zolmitriptan tablets are part of an “ever-growing portfolio” that the company has developed for the US market.
